SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057007
Filing Date
2024-05-09
Accepted
2024-05-09 16:17:21
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aclx-20240331.htm   iXBRL 10-Q 1546266
2 EX-31.1 aclx-ex31_1.htm EX-31.1 13068
3 EX-31.2 aclx-ex31_2.htm EX-31.2 13071
4 EX-32.1 aclx-ex32_1.htm EX-32.1 7692
5 EX-32.2 aclx-ex32_2.htm EX-32.2 7918
  Complete submission text file 0000950170-24-057007.txt   5616200

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aclx-20240331.xsd EX-101.SCH 1182209
56 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20240331_htm.xml XML 523878
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41259 | Film No.: 24930944
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)